newsfilter
← Latest News
PR Newswire·

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in Replimune Group, Inc. Lawsuit - REPL

REPL
  • The Gross Law Firm issued a notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL) regarding a potential class action.
  • The class period is defined as October 20, 2025, to April 10, 2026.
  • Allegations state that defendants issued misleading statements or failed to disclose that FDA study design concerns were not addressed in connection with the BLA.
  • The complaint alleges the company submitted data from an early unplanned analysis of RP1-104 involving only 40 patients instead of the planned 400.
  • Deficiencies in RPL-001-16 & RP1-104 are claimed to likely cause FDA rejection of the BLA.
  • Shareholders are encouraged to register by the deadline of October 5, 2026, to potentially seek lead plaintiff appointment.
  • Participation incurs no cost or obligation, & registered shareholders will be enrolled in portfolio monitoring software for case updates.
  • The firm represents that false statements or omissions led to artificial inflation of the company's stock.